The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice

Pharmacological Reports

Volumn 68, Issue 2, 2016, Pages 275-282

  Abu Elsaad, Nashwa M ^a   Serrya, Marwa S ^a   El Karef, Amr M ^b   Ibrahim, Tarek M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

17 AAG; Apoptosis; Heat shock protein; Liver fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; HEAT SHOCK PROTEIN 90; HYDROXYPROLINE; MESSENGER RNA; METALLOPROTEINASE; TANESPIMYCIN; THIOACETAMIDE; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; BENZOQUINONE DERIVATIVE; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; FAS ANTIGEN; GLUTATHIONE; MACROCYCLIC LACTAM; MALONALDEHYDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LIVER LOBULE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; THIOACETAMIDE-INDUCED LIVER FIBROSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER CIRRHOSIS; METABOLISM;

ACTINS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BENZOQUINONES; CASPASE 3; COLLAGEN TYPE I; GLUTATHIONE; HSP90 HEAT-SHOCK PROTEINS; LACTAMS, MACROCYCLIC; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; MICE; OXIDATIVE STRESS; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84950335496     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.08.015     Document Type: Article

References (44)

1. Z. Li, and P. Srivastava Heat-shock proteins Curr Protoc Immunol 2004 A-1T
2. T. Scheibel, and J. Buchner The Hsp90 complex-a super-chaperone machine as a novel drug target Biochem Pharmacol 56 6 1998 675 682
3. D. Picard Heat-shock protein 90, a chaperone for folding and regulation Cell Mol Life Sci 59 10 2002 1640 1648
4. M.J. Schlesinger Heat shock proteins J Biol Chem 265 21 1990 12111 12114
5. W.G. An, T.W. Schulte, and L.M. Neckers The heat shock protein 90 antagonist Geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome Cell Growth Differ 11 7 2000 355 360
6. L. Neckers Heat shock protein 90: the cancer chaperone J Biosci 32 3 2007 517 530
7. R.B. Den, and B. Lu Heat shock protein 90 inhibition: rationale and clinical potential Ther Adv Med Oncol 4 4 2012 211 218
8. L. Whitesell, E.G. Mimnaugh, B. De Costa, C.E. Myers, and L.M. Neckers Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation Proc Natl Acad Sci 91 18 1994 8324 8328
9. Y. Uehara Natural product origins of Hsp90 inhibitors Curr Cancer Drug Targets 3 5 2003 325 330
10. T.J. Yun, E.K. Harning, K. Giza, D. Rabah, P. Li, J.W. Arndt, and et al. EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity J Immunol 186 1 2011 563 575
11. J. Madrigal-Matute, O. López-Franco, L.M. Blanco-Colio, B. Muñoz-García, P. Ramos-Mozo, L. Ortega, and et al. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis Cardiovasc Res 86 2 2010 330 337
12. G. Pockley Heat shock proteins, inflammation, and cardiovascular disease Circulation 105 8 2002 1012 1017
13. A. Chatterjee, C. Dimitropoulou, F. Drakopanayiotakis, G. Antonova, C. Snead, J. Cannon, and et al. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis Am J Respir Crit Care Med 176 7 2007 667 675
14. M. Breinig, E. Caldas-Lopes, B. Goeppert, M. Malz, R. Rieker, F. Bergmann, and et al. Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma Hepatology 50 1 2009 102 112
15. S.A. Lang, C. Christian Moser, S. Fichnter-Feigl, P. Schachtschneider, C. Hellerbrand, V. Schmitz, and et al. Targeting heat shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice Hepatology 49 2 2009 523 532
16. A. Ambade, D. Catalano, A. Lim, and P. Mandrekar Inhibition of heat shock protein (Molecular Weight 90 KDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice Hepatology 55 5 2012 1585 1595
17. J. Hu, D. Flores, D. Toft, X. Wang, and D. Nguyen Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function J Virol 78 23 2004 13122 13131
18. S. Ujino, S. Yamaguchi, K. Shimotohno, and H. Takaku Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3 J Biol Chem 284 11 2009 6841 6846
19. S.J. Myung, J. Yoon, B.H. Kim, J.H. Lee, E.U. Jung, and H.S. Lee Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells JPET 330 1 2009 276 282
20. I.S. Chen, Y.C. Chen, C.H. Chou, R.F. Chuang, L.Y. Sheen, and C.H. Chiu Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis J Sci Food Agric 92 7 2012 1441 1447
21. L.E. Palacios, and T. Wang Egg-yolk lipid fractionation and lecithin characterization J Am Oil Chem Soc 82 8 2005 571 578
22. J. James, K.S. Bosch, D.C. Aronson, and J.M. Houtkooper Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver Liver 10 1 1990 1 5
23. H.S. Lee, C.T. Shun, L.L. Chiou, C.H. Chen, G.T. Huang, and J.C. Sheu Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: emphasis on sampling variability J Gastroenterol Hepatol 20 7 2005 1109 1114
24. D. Gérard-Monnier, I. Erdelmeier, K. Regnard, N. Moze-Henry, J.C. Yadan, and J. Chaudiere Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals analytical applicatioins to a colorimetric assay of lipid peroxidation Chem Res Toxicol 11 10 1998 1176 1183
25. M.S. Moron, J.W. Depierre, and B. Mannervik Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver BBA - Gen. Subj. 582 1 1979 67 78
26. F. Nozu, N. Takeyama, and T. Tanaka Changes of hepatic fatty acid metabolism produced by chronic thioacetamide administration in rats Hepatology 15 6 1992 1099 1106
27. E. Albanis, and S.L. Friedman Hepatic fibrosis: pathogenesis and principles of therapy Clin Liver Dis 5 2 2001 315 334
28. R. Urtasun, L. Conde de la Rosa, and N. Nieto Oxidative and nitrosative stress and fibrogenic response Clin Liver Dis 12 4 2008 769 790
29. G. Carpino, S. Morini, S. Ginanni-Corradini, A. Franchitto, M. Merli, M. Siciliano, and et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation Dig Liver Dis 37 5 2005 349 356
30. A.Y. Hui, and S.L. Friedman Molecular basis of hepatic fibrosis Expert Rev Mol Med 5 05 2003 1 23
31. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 6 2008 1655 1669
32. R. Bataller, and D.A. Brenner Hepatic stellate cells as a target for the treatment of liver fibrosis Semin Liver Dis 21 3 2001 437 451
33. J.A. Fallowfield Therapeutic targets in liver fibrosis Am J Physiol Gastrointest Liver Physiol 300 5 2011 G709 G715
34. L. Neckers, and S.P. Ivy Heat shock protein 90 Curr Opin Oncol 15 6 2003 419 424
35. P. Mandrekar, D. Catalano, V. Jeliazkova, and K. Kodys Alcohol exposure regulates heat shock transcription factor binding and heat shock proteins 70 and 90 in monocytes and macrophages: implication for TNF-alpha regulation J Leukoc Biol 84 5 2008 1335 1345
36. W.M. Rosenberg, M. Voelker, R. Thiel, M. Becka, A. Burt, D. Schuppan, and et al. Automated assays of serum markers of liver fibrosis predict histologic hepatic fibrosis Hepatology 32 4 2000 183A
37. S.K. Natarajan, S. Thomas, P. Ramamoorthy, J. Basivireddy, A.B. Pulimood, A. Ramachandran, and et al. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models J Gastroenterol Hepatol 21 6 2006 947 957
38. P. Viatour, M.P. Merville, V. Bours, and A. Chariot Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation Trends Biochem Sci 30 1 2005 43 52
39. Y. Zhang, X. Yao, and X. Zhao Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells World J Gastroenterol 12 9 2006 1392 1396
40. F.F. Mohammed, C.J. Pennington, Z. Kassiri, J.S. Rubin, P.D. Soloway, U. Ruther, and et al. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration Hepatology 41 4 2005 857 867
41. S. Hemmann, J. Graf, M. Roderfeld, and E. Roeb Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies J Hepatol 46 5 2007 955 975
42. A.M. Preaux, M.P. D'Ortho, M.P. Bralet, Y. Laperche, and P. Mavier Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2 Hepatology 36 3 2002 615 622
43. F.R. Murphy, R. Issa, X. Zhou, S. Ratnarajah, H. Nagase, M.J. Arthur, and et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis J Biol Chem 277 13 2002 11069 11076
44. J.B. Chakraborty, F. Oakley, and M.J. Walsh Mechanisms and biomarkers of apoptosis in liver disease and fibrosis Intern J Hepatol 2012 1 10